Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    Synovial Sarcoma Conference

    Inaugural Synovial Sarcoma Conference

    April 7, 2025 joshs Comments Off on Inaugural Synovial Sarcoma Conference
    A man in a gray suit sits in a modern, well-lit office lounge. Text on the image reads: "Dr. Theodore Laetsch, Lead Investigator & Medical Director, SSF." Blue chairs and large windows are in the background.

    On March 1, CHOP, in collaboration with Penn Medicine and the Synovial Sarcoma Foundation, hosted the first-ever national virtual conference dedicated solely to synovial sarcoma. More than 100 patients, caregivers, researchers, and clinicians attended the event, which featured expert presentations, research updates, and live discussions.

    The Synovial Sarcoma Foundation is dedicated to advancing research and support for patients affected by this rare form of cancer.

    Conference Recording: 

    View the complete conference recording: Watch Video
    Review presentation slides from featured speakers: View Presentations
    Read answers to participant-submitted questions: Read Q&A

    joshs

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Children (1)
    • CHOP (3)
    • Development (4)
    • Dr. Theodore Laetsch (3)
    • Education (6)
    • Healthcare (5)
    • Latest News (6)
    • Research (15)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A scientist wearing safety glasses and gloves closely examines samples through a microscope in a laboratory setting, concentrating on her research.
      Afamitresgene Autoleucel (Afami-cel): T-Cell Therapy Shows Promise in Synovial Sarcoma
    • A virtual meeting with five professionals, three men and two women, each in their own space, looking at their cameras. Names and titles are displayed for some participants at the bottom of their video frames.
      Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum
    • A scientist in blue scrubs looks into a microscope in a modern laboratory, surrounded by glassware, test tubes, and laboratory equipment with shelves of supplies in the background.
      Rethinking the Driver: New Research Identifies P300 as a Critical Co-Factor in Synovial Sarcoma

    Tags

    Afami-cel Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Chase Spence Chas Spence CHOP Dr. Rachel Hurly Dr. Ted Laetsch fibroblast fibroblast epigenome ground breaking human cell therapy immune-cell therapy Infant JAMA Internal Medicine Julie Kramer MAGE-A4 Market Growth Monophasic Synovial Sarcoma Nathan Imperiale National Tumor Board Nature Communications P300 Parotid Gland Patient Stories Pediatric Oncology Penn Medicine Penn Medicine Synovial Sarcoma Foundation Prasterone Rare Cancer research Sarcoma Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment T-Cell Therapy TCR-NK TECELRA webinar Zelluna ZI-MA4-1

    Related posts

    Three medical professionals walk and talk in a bright hallway. One wears a white coat with a stethoscope, while the others wear scrubs. Two more people in white coats are visible on the stairs in the background.
    Research, Education, Synovial Sarcoma Registry

    Rise in Early-Onset Cancers: More Diagnoses, Not Always More Disease

    October 3, 2025 nathani Comments Off on Rise in Early-Onset Cancers: More Diagnoses, Not Always More Disease

    Not every detected cancer is clinically meaningful. For younger patients, especially, this can mean confronting a diagnosis that may never progress but still carries psychological and treatment burdens.

    A man in a gray suit sits in a modern, well-lit office lounge. Text on the image reads: "Dr. Theodore Laetsch, Lead Investigator & Medical Director, SSF." Blue chairs and large windows are in the background.
    CHOP, Dr. Theodore Laetsch

    Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

    September 29, 2025 joshs Comments Off on Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

    The Synovial Sarcoma Foundation is pleased to highlight a significant milestone at the Children’s Hospital of Philadelphia (CHOP), where pediatric oncologist and Synovial Sarcoma Foundation Board Member, Dr. Theodore W. Laetsch, has been awarded a prestigious $1 million multi-year grant from the National Cancer Institute (NCI). This funding aims to accelerate research and treatment development […]

    A smiling woman with glasses holds an award plaque in front of a backdrop featuring “CONQUER CANCER,” “RESEARCH CONQUERS CANCER,” and Synovial Sarcoma Foundation logos from The ASCO Foundation.
    CHOP, Development, Dr. Theodore Laetsch, Research

    Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

    June 3, 2025 joshs Comments Off on Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

    The Synovial Sarcoma Foundation is proud to announce a significant milestone in pediatric cancer research: Dr. Rachel Hurly, a dedicated pediatric oncology fellow from the Children’s Hospital of Philadelphia (CHOP), has been honored with the prestigious American Society of Clinical Oncology (ASCO) Young Investigator Award. Dr. Hurly conducts her research under the mentorship of Dr. Ted Laetsch at the Haldor Laboratory at the University of Pennsylvania, with support from the Synovial Sarcoma Fund.

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch